| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT01551368 | Infertility | Drug: Nimodipine|Drug: Placebo | Mount Sinai Hospital, Canada | Phase 2 | 2012-12-01 | 2016-05-04 |
| NCT01835665 | Progranulin Mutation Carriers | Drug: Nimodipine | University of California, San Francisco|The Bluefield Project | Phase 1 | 2013-03-01 | 2016-05-12 |
| NCT02790632 | Subarachnoid Hemorrhage, Aneurysmal | Drug: EG-1962 (nimodipine microparticles)|Drug: Enteral Nimodipine | Edge Therapeutics Inc | Phase 3 | 2016-07-01 | 2017-02-27 |
| NCT02537080 | Mild Cognitive Impairment | Drug: Nimodipine group|Drug: Control group | University Hospital Hradec Kralove | | 2015-09-01 | 2016-10-15 |
| NCT01672801 | Unexplained Infertility|Polycystic Ovarian Syndrome|Anovulatory | Drug: Placebo|Drug: Nimodipine | Boston IVF|Village Fertility Pharmacy | | 2012-09-01 | 2016-01-11 |
| NCT02248233 | Cerebral Infarction | Drug: Nimodipine|Drug: Saline + citicoline | Fengtian Hospital | Phase 4 | 2014-10-01 | 2014-10-14 |
| NCT01893190 | Ruptured Cerebral Aneurysm|Ruptured Berry Aneurysm | Drug: Nimodipine|Drug: Nimodipine Microparticles | Edge Therapeutics Inc | Phase 1|Phase 2 | 2013-09-01 | 2016-01-19 |
| NCT00781326 | Depression | Drug: Nimodipine|Drug: Placebo | University of Pittsburgh|National Institute of Mental Health (NIMH) | Phase 4 | 2008-08-01 | 2016-08-05 |
| NCT02893826 | Subarachnoid Hemorrhage, Aneurysmal | Drug: EG-1962 (nimodipine microparticles)|Drug: Enteral Nimodipine | Edge Therapeutics Inc | Phase 1 | 2016-09-01 | 2017-03-24 |
| NCT00000332 | Cocaine-Related Disorders | Drug: Nimodipine | National Institute on Drug Abuse (NIDA)|Washington D.C. Veterans Affairs Medical Center | Phase 2 | 1998-05-01 | 2017-02-23 |
| NCT00000738 | AIDS Dementia Complex|HIV Infections | Drug: Nimodipine|Drug: Zidovudine | National Institute of Allergy and Infectious Diseases (NIAID)|Miles|Glaxo Wellcome | Phase 1 | null | 2012-03-30 |
| NCT02991157 | Subarachnoid Hemorrhage, Aneurysmal | Drug: Nimodipine | National Institute of Mental Health and Neuro Sciences, India | | 2016-12-01 | 2016-12-09 |
| NCT03028090 | Indication for Peripheral Intravenous Catheterization | Device: SHERLOCK 3CG鈩?Tip Confirmation System with MODUS Software | C. R. Bard | | 2013-11-01 | 2017-01-18 |
| NCT00004399 | Pre-eclampsia | Drug: magnesium sulfate|Drug: nimodipine | FDA Office of Orphan Products Development|University of Utah | | 1995-09-01 | 2015-03-24 |
| NCT02165644 | Acute Cerebrovascular Accident|Vasospasm | Drug: Acetazolamide|Drug: Nimodipine | University of Florida | Phase 2 | 2015-09-01 | 2015-09-23 |
| NCT00814658 | Dementia | Drug: Galantamine|Drug: Nimodipine|Drug: Placebo | Janssen-Cilag Farmaceutica Ltda. | Phase 4 | 2008-06-01 | 2013-08-22 |
| NCT00000280 | Cocaine-Related Disorders | Drug: Nimodipine | Yale University|National Institute on Drug Abuse (NIDA)|VA Connecticut Healthcare System | Phase 1 | 1994-09-01 | 2013-07-24 |
| NCT02983396 | Chest Pain|ST Elevation Myocardial Infarction | Device: Diagnostic accuracy of Mini Relf Device | University Ghent | | 2016-11-01 | 2016-12-01 |
| NCT00317213 | Smoking | Drug: LIBERTAL- a phospholipid mixture | Kaplan Medical Center|Modus Biological Membranes, Ltd. | Phase 2 | 2002-02-01 | 2008-04-09 |
